Overcoming the UCB HSCs -Derived NK cells Dysfunction through Harnessing RAS/MAPK, IGF-1R and TGF-β Signaling Pathways.
Alireza ShokouhifarGholamreza Anani SarabMahboubeh YazdanifarMohammad FereidouniMasoumeh NouriMarzieh EbrahimiPublished in: Cancer cell international (2021)
The differentiation of ex vivo expanded CD34 + cells through manipulation of RAS/MAPK, IGF-1R and TGF-β signaling pathways is an efficient approach for generating functional NK cells that can be used for cancer immunotherapy.